At present, effective antivirals against the coronavirus infection disease 2019 (COVID-19) do not seem to be available, and hence medical practitioners and governments are vying for any useful information on the treatment and management of this outbreak. Research journals have played their part by promoting COVID-19 research to ensure that the stakeholders have immediate access to adequate information. Some journals have fast-tracked the COVID-19 papers, and a few other journals have waived the publication fee to encourage sharing of experience from the developing countries.1 Special issues have been another option for some journals. These affirmative actions have helped in sharing vital information on the treatment and management of this pandemic.
展开▼
